« Equity Financing | Main | Initiation of Phase I Part B »
Wednesday
Jan272016

Innovation Foundation Grant

MinervaX announces that the company has been awarded a grant worth DKK 4.5 million (EUR 0.6 million) from the Danish Innovation Foundation, under the Innobooster Programme, for the development of its Group B Streptococcal Vaccine.